Quanterix Corporation (QTRX) financial statements (2022 and earlier)

Company profile

Business Address 900 MIDDLESEX TURNPIKE
BILLERICA, MA 01821
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments396,465410,747430,780442,672181,584173,16288,806
Cash and cash equivalents396,465410,747430,780442,672181,584173,16288,806
Restricted cash and investments    1,000  
Receivables23,98618,60415,56415,07317,35626,3359,634
Inventory, net of allowances, customer advances and progress billings22,19022,79421,22517,04414,85613,27413,789
Inventory22,19022,79421,22517,04414,85613,27413,789
Other undisclosed current assets6,3147,2848,8717,6544,8092,1572,009
Total current assets:448,955459,429476,440482,443219,605214,928114,238
Noncurrent Assets
Operating lease, right-of-use asset11,49111,62611,75411,87011,99512,01912,120
Property, plant and equipment17,96016,46615,77814,18313,91212,82712,353
Intangible assets, net (including goodwill)20,16621,27722,29522,39724,17622,95622,700
Goodwill9,6329,90310,1219,93310,4609,7149,390
Intangible assets, net (excluding goodwill)10,53411,37412,17412,46413,71613,24213,310
Restricted cash and investments2,5771,6581,4001,4001,0001,0001,000
Other noncurrent assets378384377373357375529
Total noncurrent assets:52,57251,41151,60450,22351,44049,17748,702
TOTAL ASSETS:501,527510,840528,044532,666271,045264,105162,940
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities28,94720,87520,86419,12122,42117,17712,850
Accounts payable9,2095,8246,8626,5036,7995,9624,878
Accrued liabilities6,4865,8755,0835,6034,8454,1772,597
Employee-related liabilities13,2529,1768,9197,01510,7777,0385,375
Deferred revenue6,3615,7436,1496,4205,4213,7935,019
Debt 1,9937,7168,9658,9076,910729
Due to related parties422510    
Other liabilities2411,2051,6241,9853,054212299
Other undisclosed current liabilities1,3861,3491,312    
Total current liabilities:36,97731,19037,67536,49139,80328,09218,897
Noncurrent Liabilities
Long-term debt and lease obligation20,46420,84521,21021,55221,89124,06630,088
Long-term debt, excluding current maturities     1,9077,630
Operating lease, liability20,46420,84521,21021,55221,89122,15922,458
Liabilities, other than long-term debt3,1343,2913,1493,1543,2262,9062,921
Deferred revenue1,099929740776577363384
Deferred income tax liabilities2,0352,3622,409    
Other liabilities   2,3782,6492,5432,537
Total noncurrent liabilities:23,59824,13624,35924,70625,11726,97233,009
Total liabilities:60,57555,32662,03461,19764,92055,06451,906
Stockholders' equity
Stockholders' equity attributable to parent440,952455,514466,010471,469206,125209,041111,034
Common stock37373736323228
Additional paid in capital745,936739,862734,170728,128451,433446,228351,188
Accumulated other comprehensive income (loss)4411,0511,5781,1832,434734(26)
Accumulated deficit(305,462)(285,436)(269,775)(257,878)(247,774)(237,953)(240,156)
Total stockholders' equity:440,952455,514466,010471,469206,125209,041111,034
TOTAL LIABILITIES AND EQUITY:501,527510,840528,044532,666271,045264,105162,940

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues30,28727,68925,37127,20926,13131,38913,130
Cost of revenue(14,026)(12,445)(11,497)(10,860)(11,081)(10,283)(7,917)
Gross profit:16,26115,24413,87416,34915,05021,1065,213
Operating expenses(36,157)(30,477)(27,542)(26,138)(24,983)(18,828)(17,414)
Operating income (loss):(19,896)(15,233)(13,668)(9,789)(9,933)2,278(12,201)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(213)(305)1,977(194)155(26)(11)
Income (loss) from continuing operations before equity method investments, income taxes:(20,109)(15,538)(11,691)(9,983)(9,778)2,252(12,212)
Other undisclosed income (loss) from continuing operations before income taxes15(90)(165)(163)(166)(160)(108)
Income (loss) from continuing operations before income taxes:(20,094)(15,628)(11,856)(10,146)(9,944)2,092(12,320)
Income tax expense (benefit)68(33)(41)4212311118
Net income (loss) available to common stockholders, diluted:(20,026)(15,661)(11,897)(10,104)(9,821)2,203(12,302)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(20,026)(15,661)(11,897)(10,104)(9,821)2,203(12,302)
Comprehensive income (loss):(20,026)(15,661)(11,897)(10,104)(9,821)2,203(12,302)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(610)(527)395(1,251)1,7007601,174
Comprehensive income (loss), net of tax, attributable to parent:(20,636)(16,188)(11,502)(11,355)(8,121)2,963(11,128)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: